| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.PBB.2005.01.032 |
| P8608 | Fatcat ID | release_3thz6nepwrb23nof7jt4fqwgpe |
| P698 | PubMed publication ID | 15936806 |
| P5875 | ResearchGate publication ID | 7805123 |
| P2093 | author name string | Eliot L Gardner | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocannabinoid system | Q368952 |
| P304 | page(s) | 263-284 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
| P1476 | title | Endocannabinoid signaling system and brain reward: emphasis on dopamine | |
| P478 | volume | 81 |
| Q38036236 | A brain on cannabinoids: the role of dopamine release in reward seeking |
| Q34098873 | A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study |
| Q36741898 | A neuropeptide-centric view of psychostimulant addiction |
| Q38348213 | A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use |
| Q37427268 | A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice |
| Q37208086 | A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions |
| Q35552364 | A survey study to characterize use of Spice products (synthetic cannabinoids). |
| Q37765676 | A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia |
| Q36636653 | Acute effects of THC on time perception in frequent and infrequent cannabis users |
| Q37408145 | Adaptations of striatal endocannabinoid system during stress. |
| Q35995170 | Addiction and brain reward and antireward pathways |
| Q24676705 | Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain |
| Q28286488 | Adenosine-cannabinoid receptor interactions. Implications for striatal function |
| Q34098209 | Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models |
| Q28544894 | Alterations of monetary reward and punishment processing in chronic cannabis users: an FMRI study |
| Q48485540 | Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats |
| Q34098204 | Animal models of cannabinoid reward |
| Q34234907 | Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis |
| Q48100292 | Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems |
| Q46689323 | Anxiolytic-like properties of the anandamide transport inhibitor AM404. |
| Q36026092 | Area-specific analysis of the distribution of hypothalamic neurons projecting to the rat ventral tegmental area, with special reference to the GABAergic and glutamatergic efferents |
| Q35062688 | Association of the calcyon neuron-specific vesicular protein gene (CALY) with adolescent smoking initiation in China and California |
| Q48145676 | Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence |
| Q35626928 | Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2. |
| Q90217765 | Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons |
| Q100696968 | Beta-caryophyllene inhibits cocaine self-administration by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder |
| Q90524726 | Brain activity of anandamide: a rewarding bliss? |
| Q33293362 | CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health |
| Q35647941 | Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence |
| Q37019861 | Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior |
| Q89394372 | Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats |
| Q33980198 | Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future |
| Q37132683 | Cannabinoid modulation of amygdala reactivity to social signals of threat in humans |
| Q34899462 | Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. |
| Q36342981 | Cannabinoid receptor 1-expressing neurons in the nucleus accumbens |
| Q36174329 | Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways |
| Q37734568 | Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. |
| Q37612419 | Cannabinoid-hormone interactions in the regulation of motivational processes |
| Q34320242 | Cannabinoids and hallucinogens for headache |
| Q28241328 | Cannabinoids and psychosis |
| Q36977777 | Cannabinoids in eating disorders and obesity |
| Q89510317 | Cannabis Sativa Revisited-Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis |
| Q24628837 | Cannabis and psychosis/schizophrenia: human studies |
| Q36757474 | Cannabis cue-elicited craving and the reward neurocircuitry |
| Q37029485 | Cannabis in sport: anti-doping perspective |
| Q37086175 | Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor |
| Q47328661 | Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism |
| Q34699888 | Cannabis, the mind and society: the hash realities |
| Q43168358 | Central nervous system effects of haloperidol on THC in healthy male volunteers |
| Q42379921 | Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography |
| Q33587870 | Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol |
| Q46058078 | Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes |
| Q28385443 | Cognitive motor deficits in cannabis users |
| Q34067376 | Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review |
| Q24645385 | Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study |
| Q35784024 | Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence |
| Q30470474 | Decreased reward sensitivity in rats from the Fischer344 strain compared to Wistar rats is paralleled by differences in endocannabinoid signaling |
| Q52148259 | Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity. |
| Q37417075 | Deletion of vanilloid receptor (TRPV1) in mice alters behavioral effects of ethanol |
| Q86825974 | Delineation of domains within the cannabinoid CB1 and dopamine D2 receptors that mediate the formation of the heterodimer complex |
| Q46406572 | Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum |
| Q33575152 | Differential effects of presynaptic versus postsynaptic adenosine A2A receptor blockade on Δ9-tetrahydrocannabinol (THC) self-administration in squirrel monkeys. |
| Q90263481 | Differential effects of Δ9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model |
| Q38564008 | Dissecting the cannabinergic control of behavior: The where matters |
| Q24681363 | Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. |
| Q42175610 | Dopaminergic Neurotransmission in the Nucleus Accumbens Modulates Social Play Behavior in Rats |
| Q95820099 | Dual-Layered Nanomaterial-Based Molecular Pattering on Polymer Surface Biomimetic Impedimetric Sensing of a Bliss Molecule, Anandamide Neurotransmitter |
| Q30489165 | Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats |
| Q35682364 | Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens |
| Q46160324 | Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice |
| Q33886277 | Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans |
| Q45210449 | Effects of nicotine on homeostatic and hedonic components of food intake |
| Q35203644 | Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia |
| Q34167669 | Effects of the cannabinoid CB₁ receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats |
| Q47930409 | Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism |
| Q34602346 | Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits |
| Q39400299 | Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling |
| Q92097847 | Endocannabinoid System and Alcohol Abuse Disorders |
| Q34003324 | Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward |
| Q35532072 | Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors |
| Q35679432 | Endocannabinoid signaling and long-term synaptic plasticity. |
| Q34967151 | Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? |
| Q36357182 | Endocannabinoid system involvement in brain reward processes related to drug abuse |
| Q93046837 | Endocannabinoids Interact With the Dopaminergic System to Increase Sexual Motivation: Lessons From the Sexual Satiety Phenomenon |
| Q55452539 | Endocannabinoids and Schizophrenia. |
| Q88924595 | Endocannabinoids in Body Weight Control |
| Q36395277 | Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. |
| Q34383507 | Explaining human recreational use of 'pesticides': The neurotoxin regulation model of substance use vs. the hijack model and implications for age and sex differences in drug consumption. |
| Q55300833 | Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens. |
| Q36718290 | Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice |
| Q33336552 | Feeding induced by cannabinoids is mediated independently of the melanocortin system |
| Q30354013 | Framework for sex differences in adolescent neurobiology: a focus on cannabinoids. |
| Q36751811 | Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum |
| Q27315226 | Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors |
| Q26865311 | Gone to Pot - A Review of the Association between Cannabis and Psychosis |
| Q55346929 | Hedonic Eating and the "Delicious Circle": From Lipid-Derived Mediators to Brain Dopamine and Back. |
| Q46652152 | Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice |
| Q34318345 | Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferences |
| Q93047061 | Hypothalamic Fatty Acids and Ketone Bodies Sensing and Role of FAT/CD36 in the Regulation of Food Intake |
| Q36452302 | Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. |
| Q36652502 | Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. |
| Q60583030 | Implicación del sistema cannabinoide endógeno en el alcoholismo |
| Q43235028 | Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain |
| Q38757749 | Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms |
| Q35053193 | Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies |
| Q48164825 | Intra-accumbal Cannabinoid Agonist Attenuated Reinstatement but not Extinction Period of Morphine-Induced Conditioned Place Preference; Evidence for Different Characteristics of Extinction Period and Reinstatement |
| Q35833732 | Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat. |
| Q47108509 | Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. |
| Q40670083 | Involvement of the endocannabinoid system in reward processing in the human brain |
| Q46755929 | Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo |
| Q39098495 | Is there a role for cannabidiol in psychiatry? |
| Q26799231 | Legal highs: staying on top of the flood of novel psychoactive substances |
| Q37164807 | Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond |
| Q63197672 | Low anandamide doses facilitate male rat sexual behaviour through the activation of CB1 receptors |
| Q21090461 | Marijuana: current concepts(†) |
| Q30489086 | Maternal separation alters drug intake patterns in adulthood in rats |
| Q38523248 | Medical Marijuana in Pediatric Neurological Disorders |
| Q36309904 | Microinjection of WIN55,212-2 as A Cannabinoid Agonist into The Basolateral Amygdala Induces Sensitization to Morphine in Rats |
| Q27014154 | Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction |
| Q46570608 | Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers |
| Q34172647 | Neonatal maternal separation exacerbates the reward-enhancing effect of acute amphetamine administration and the anhedonic effect of repeated social defeat in adult rats |
| Q30547526 | Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder |
| Q38338793 | Neurobiological Bases of Cue- and Nicotine-induced Reinstatement of Nicotine Seeking: Implications for the Development of Smoking Cessation Medications |
| Q42061836 | Neuroimaging evidence for cannabinoid modulation of cognition and affect in man. |
| Q34582857 | Neuroimaging revolutionizes therapeutic approaches to chronic pain |
| Q34205532 | Neuropharmacology of learned flavor preferences |
| Q38016798 | New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance. |
| Q48255516 | Nicotine increases FosB expression within a subset of reward- and memory-related brain regions during both peri- and post-adolescence |
| Q50074099 | Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour. |
| Q35493939 | Paradoxical Decrease in Striatal Activation on an fMRI Reward Task Following Treatment in Youth with Co-morbid Cannabis Dependence/Major Depression |
| Q34378233 | Pathways from cannabis to psychosis: a review of the evidence |
| Q24648976 | Pharmacotherapy for cannabis dependence: how close are we? |
| Q34605939 | Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. |
| Q46617027 | Polydrug use, cannabis, and psychosis-like symptoms |
| Q90248156 | Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders |
| Q34359231 | Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system |
| Q37414652 | Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms. |
| Q43201051 | Psychosis following anti-obesity treatment with rimonabant. |
| Q37164815 | Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure |
| Q37329121 | Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid |
| Q35046370 | Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist |
| Q81099416 | Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats |
| Q53099589 | Risky cannabis use is associated with alexithymia, frontal lobe dysfunction, and impulsivity in young adult cannabis users. |
| Q34573261 | Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase |
| Q37129779 | Role of endocannabinoids in regulating drug dependence |
| Q36030335 | Role of systemic endocannabinoid CB-1 receptor antagonism in the acquisition and expression of fructose-conditioned flavor-flavor preferences in rats |
| Q41863571 | Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain |
| Q36826548 | Steroidogenic factor 1 regulates expression of the cannabinoid receptor 1 in the ventromedial hypothalamic nucleus |
| Q48966323 | Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study |
| Q64229781 | The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder |
| Q50226059 | The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction. |
| Q26752942 | The Influence of Palatable Diets in Reward System Activation: A Mini Review |
| Q58707392 | The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity |
| Q36288031 | The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding |
| Q24643876 | The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin |
| Q36630516 | The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing |
| Q35989527 | The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism. |
| Q34587990 | The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q36741861 | The endocannabinoid system in brain reward processes |
| Q42761450 | The endocannabinoid system modulates the valence of the emotion associated to food ingestion |
| Q37291517 | The endocannabinoid system: a new molecular target for the treatment of tobacco addiction. |
| Q34567576 | The endocannabinoid/endovanilloid system and depression |
| Q37936694 | The genetic basis of the endocannabinoid system and drug addiction in humans. |
| Q38944421 | The neurobiology of social play and its rewarding value in rats |
| Q38072364 | The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects |
| Q91042528 | The relation between dopamine D2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients |
| Q34320270 | The role of endocannabinoids in pain modulation |
| Q38639956 | Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation. |
| Q42700539 | Using Functional Near-Infrared Spectroscopy to Measure Effects of Delta 9-Tetrahydrocannabinol on Prefrontal Activity and Working Memory in Cannabis Users |
| Q92878129 | Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons |
| Q39538303 | ∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells. |
Search more.